⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3489355 | 1.00 | — | — | |
| SCHEMBL14396895 | 1.00 | — | — | |
| SCHEMBL10087523 | 0.81 | — | — | |
| SCHEMBL30667393 | 0.81 | — | — | |
| SCHEMBL25940445 | 0.81 | — | — | |
| SCHEMBL27268798 | 0.80 | LMNA (0.33) | — | |
| SCHEMBL13910025 | 0.79 | — | — | |
| SCHEMBL12296103 | 0.79 | — | — | |
| SCHEMBL12295214 | 0.79 | — | — | |
| SCHEMBL13464540 | 0.79 | HIF1A (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102241736-B | Method for synthesizing key intermediate of antitumour medicament Romidepsi | JASUN PHARMCHEM CO LTD | 2013-06-26 | — | — | CN | claimed |
| CN-102241736-A | Method for synthesizing key intermediate of antitumour medicament Romidepsi | JASUN PHARMCHEM CO LTD | 2011-11-16 | — | — | CN | claimed |
| CN-115141267-B | Polypeptide for improving sensitivity of stomach cancer cisplatin chemotherapy and application thereof | 江苏省肿瘤医院 | 2025-06-03 | — | — | CN | disclosed |
| CN-117442748-A | Multivalent mimotopes, mimotope binding antibodies and uses thereof | 希望之城公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-106999587-B | Multivalent mimotopes, mimotope binding antibodies and uses thereof | 希望之城公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-115141267-A | Polypeptide for improving gastric cancer cisplatin chemotherapy sensitivity and application thereof | 江苏省肿瘤医院 | 2022-10-04 | — | — | CN | disclosed |
| CN-106715460-B | Novel peptide derivative and use thereof | 诺索药业公司 | 2022-04-08 | — | — | CN | disclosed |
| WO-2021051766-A1 | METHOD FOR SYNTHESIZING OCTREOTIDE | 深圳翰宇药业股份有限公司 | 2021-03-25 | — | — | WO | disclosed |
| CN-106999587-A | Multivalent meditopes, meditope binding antibodies, and uses thereof | 希望之城公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-106715460-A | Novel peptide derivative and use thereof | 诺索药业公司 | 2017-05-24 | — | — | CN | disclosed |
| CN-104341386-A | Aryl heterocycle micromolecule compounds, derivatives thereof, and preparing methods and uses of the compounds and the derivatives | SHANGHAI INST MATERIA MEDICA | 2015-02-11 | — | — | CN | disclosed |
| US-20100068224-A1 | Method for Producing Viral Vaccine and Therapeutic Peptide Antigens | PROTELIX, INC. | 2010-03-18 | — | — | US | disclosed |
| EP-2012829-A2 | METHOD FOR PRODUCING VIRAL VACCINE AND THERAPEUTIC PEPTIDE ANTIGENS | Protelix, Inc. (US) | 2009-01-14 | — | — | EP | disclosed |
| WO-2007127290-A2 | METHOD FOR PRODUCING VIRAL VACCINE AND THERAPEUTIC PEPTIDE ANTIGENS | PROTELIX, INC. (US) | 2007-11-08 | — | — | WO | disclosed |
| CN-1085802-A | Method with granulocyte-macrophage treatment hepatitis | SCHERING CORP (US) | 1994-04-27 | — | — | CN | disclosed |